Medtronic (MDT) Reports 78% Revenue Growth in Q4 2026 Earnings
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowMedtronic plc (NYSE: MDT) achieved its highest annual revenue growth in a decade, reporting a global revenue increase of 78%, with 124% growth in the U.S. for its Cardiac Ablation Solutions. The company is focusing on innovations and acquisitions to support potential growth across its portfolio. In contrast, Tenet Healthcare Corporation (NYSE: THC) saw adjusted diluted EPS rise 52.2% year over year to $6.12, with net operating revenue climbing 6.8% to $5.63 billion. As both companies demonstrate strong performance, this information helps investors evaluate which stock might better suit their growth strategy.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Medtronic plc (MDT)
Medtronic is one of the world’s largest medical-device makers.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier MDT news
- Medtronic (MDT) Reports 9.9% Q4 Revenue Growth, UBS Upgrades Stock
- Medtronic Faces $88 Million Verdict in Hernia Mesh Trial
- Medtronic (MDT) Reports Highest Annual Revenue Growth in Decade
- Medtronic (MDT) Tariff Impact Reduces Estimates to $250 Million
- Medtronic (MDT) Reports Strong Q4 with $36 Billion Revenue Growth
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
